KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Operating Margin: 2009-2024

Historic Operating Margin for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -1.83%.

  • Teva Pharmaceutical Industries' Operating Margin rose 2086.00% to 19.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.89%, marking a year-over-year increase of 802.00%. This contributed to the annual value of -1.83% for FY2024, which is 456.00% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Operating Margin stood at -1.83% for FY2024, which was down 167.02% from 2.73% recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' Operating Margin ranged from a high of 10.81% in FY2021 and a low of -21.44% during FY2020.
  • Over the past 3 years, Teva Pharmaceutical Industries' median Operating Margin value was -1.83% (recorded in 2024), while the average stood at -4.61%.
  • Per our database at Business Quant, Teva Pharmaceutical Industries' Operating Margin surged by 3,225bps in 2021 and then slumped by 2,553bps in 2022.
  • Teva Pharmaceutical Industries' Operating Margin (Yearly) stood at -21.44% in 2020, then surged by 3,225bps to 10.81% in 2021, then plummeted by 2,553bps to -14.72% in 2022, then soared by 1,745bps to 2.73% in 2023, then crashed by 456bps to -1.83% in 2024.